The evolution of Amedisys Inc. (Nasdaq: AMED) continues.
The Baton Rouge, Louisiana-based home health, hospice and personal care provider announced early Monday morning that it has a deal in place to acquire AseraCare Hospice for $235 million. As structured, the agreement includes a $32 million tax asset, effectively lowering the overall purchase price to $203 million.
“AseraCare is a great hospice company,” Amedisys CEO and President Paul Kusserow told Home Health Care News. “When we decided that hospice was a business line we wanted to move forward in back in 2016, we actually approached AseraCare. But they weren’t for sale.”
Read more here… Home Health Care News
#hospice #mampa #mergersandacquisitions #hospicemergerandacquisition #homehealthcare